01 November 2020

Amphilix AG announce a collaboration with Eurofins Discovery


Amphilix AG is pleased to announce a collaboration with Eurofins Discovery, the leading provider of services and products to the drug discovery industry, to support a program aimed at identifying a treatment modulating key disease mechanisms. Amphilix will engage Eurofins Discovery to prosecute the biology, pharmacology, ADME, and safety pharmacology aspects of the program, working in collaboration with the accomplished team at Eurofins Discovery to progress to a development candidate. The two organizations expect this to be the first of multiple programs in which they collaborate to discover new treatments for unmet medical needs.

Contact Amphilix:

Contact Eurofins: